tirzepatide for obesity fda approval approves new weight-loss drug Zepbound (tirzepatide) FDA approves weight-loss drug Zepbound

doi: 10.1007/s11064-017-2288-7

People with a history of eating disorders shouldnt take GLP-1s

This method bypasses the digestive system, offering a convenient and effective alternative for those who prefer to avoid needles

In addition, the pleiotropic physiological effects of carnitine (e.g., antioxidant, anti-inflammatory and antiapoptotic effects) are particularly important for the protection against kidney diseases, especially drug-induced nephrotoxicity [259]

Constipation and bloating: Slowed gut motility can lead to less frequent bowel movements and persistent feelings of fullness or bloating

The most substantial and rapid changes occurred in the first three months, especially with beinaglutide in terms of BMI and weight reduction